Rezolute (RZLT) Current Assets (2011 - 2026)
Rezolute recorded quarterly Current Assets of $122.0 million in Q1 2026, down 9.66% quarter-over-quarter from $135.1 million in Q4 2025, and up 37.54% year-over-year from $88.7 million in Q1 2025.
Rezolute's Current Assets history runs 16 years deep, the most recent figure standing at $122.0 million for Q1 2026.
- In Q1 2026, Current Assets rose 37.54% year-over-year to $122.0 million; the TTM figure through Mar 2026 stood at $122.0 million (up 37.54% YoY), while the FY2025 annual figure was $171.1 million, up 33.03% from the prior year.
- Current Assets came in at $122.0 million for Q1 2026 at Rezolute, down from $135.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $171.1 million in Q2 2025 to a low of $64.3 million in Q1 2022.
- A 5-year average of $118.8 million and a median of $110.2 million in 2024 frame the typical range for Current Assets.
- Across the five-year window, Current Assets surged 305.86% in 2022 and plunged 34.9% in 2023, its largest moves.
- Rezolute's Current Assets stood at $147.6 million in 2022, then plunged by 34.9% to $96.1 million in 2023, then gained by 2.72% to $98.7 million in 2024, then jumped by 36.89% to $135.1 million in 2025, then slipped by 9.66% to $122.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $122.0 million, $135.1 million, and $154.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 122.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.05 Mn |
| Dec 31, 2025 | 135.11 Mn |
| Sep 30, 2025 | 154.71 Mn |
| Jun 30, 2025 | 171.15 Mn |
| Mar 31, 2025 | 88.74 Mn |
| Dec 31, 2024 | 98.69 Mn |
| Sep 30, 2024 | 110.18 Mn |
| Jun 30, 2024 | 128.65 Mn |
| Mar 31, 2024 | 82.21 Mn |
| Dec 31, 2023 | 96.09 Mn |
| Sep 30, 2023 | 102.65 Mn |
| Jun 30, 2023 | 104.91 Mn |
| Mar 31, 2023 | 105.53 Mn |
| Dec 31, 2022 | 147.61 Mn |
| Sep 30, 2022 | 155.63 Mn |
| Jun 30, 2022 | 152.10 Mn |
| Mar 31, 2022 | 64.33 Mn |
| Dec 31, 2021 | 78.10 Mn |
| Sep 30, 2021 | 38.35 Mn |
| Jun 30, 2021 | 41.99 Mn |
| Mar 31, 2021 | 32.20 Mn |
| Dec 31, 2020 | 38.15 Mn |
| Sep 30, 2020 | 6.90 Mn |
| Jun 30, 2020 | 10.52 Mn |
| Mar 31, 2020 | 14.17 Mn |
| Dec 31, 2019 | 19.97 Mn |
| Sep 30, 2019 | 25.92 Mn |
| Jun 30, 2019 | 12.14 Mn |
| Mar 31, 2019 | 15.36 Mn |
| Dec 31, 2018 | 422,278.00 |
| Sep 30, 2018 | 772,985.00 |
| Jun 30, 2018 | 2.01 Mn |
| Mar 31, 2018 | 445,929.00 |
| Dec 31, 2017 | 1.16 Mn |
| Sep 30, 2017 | 4.36 Mn |
| Jun 30, 2017 | 4.93 Mn |
| Mar 31, 2017 | 4.85 Mn |
| Dec 31, 2016 | 3.79 Mn |
| Sep 30, 2016 | 3.73 Mn |
| Jun 30, 2016 | 4.49 Mn |
| Mar 31, 2016 | 2.04 Mn |
| Dec 31, 2015 | 1.84 Mn |
| Sep 30, 2015 | 3.05 Mn |
| Jun 30, 2015 | 6.12 Mn |
| Mar 31, 2015 | 8.94 Mn |
| Dec 31, 2014 | 8.73 Mn |
| Sep 30, 2014 | 4.70 Mn |
| Jun 30, 2014 | 6.31 Mn |
| Mar 31, 2014 | 5.98 Mn |
| Dec 31, 2013 | 1.86 Mn |
| Sep 30, 2013 | 576,034.00 |
| Jun 30, 2013 | 815,549.00 |
| Mar 31, 2013 | 1.28 Mn |
| Jun 30, 2012 | 1.07 Mn |
| Mar 31, 2012 | 6,943.00 |
| Dec 31, 2011 | 565,789.00 |
| Sep 30, 2011 | 23,478.00 |
| Jun 30, 2011 | 37,030.00 |